Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma

被引:0
|
作者
Dosquet, C
Coudert, MC
Lepage, E
Cabane, J
Richard, F
机构
[1] Hop St Louis, Lab Cytokines, Ctr Transfus, F-75475 Paris 10, France
[2] Hop Henri Mondor, Unite Informat Med, F-94010 Creteil, France
[3] Hop St Antoine, Dept Med Interne, F-75012 Paris, France
[4] Hop La Pitie Salpetriere, Dept Urol, F-75013 Paris, France
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Angiogenesis has an important role in the progression of solid tumors, Therefore, we measured the blood levels (ELISA) of angiogenic factors [basic fibroblast growth factor (bFGF), hepatocyte growth factor/scatter factor, and vascular endothelial growth factor (VEGF)] and soluble adhesion molecules [E-selectin, intercellular adhesion molecule (ICAM-1), platelet endothelial cell adhesion molecule-1, and vascular cell adhesion molecule-1] in 76 consecutive patients with untreated renal cell carcinoma and 41 healthy controls to evaluate their prognostic value. The serum levels of bFGF, hepatocyte growth factor, and VEGF were significantly higher in patients with renal cancer than they were in healthy subjects, bFGF and VEGF values were significantly higher in patients with disseminated cancer (N+ and/or MS) than they were in those with undisseminated (M-N-) cancer: median = 27 pg/ml, range = 5-118, n = 15 versus median = 8 pg/ml, range 1-149, n = 61 (P = 10(-4)) for bFGF; and median = 883 pg/ml, range = 200-2317, n = 15 versus median = 278 pg/ml, range = 0-1704, n = 61 (P = 0.006) for VEGF, The blood levels of ICAM-1 and vascular cell adhesion molecule-1 were significantly higher, and the levels of E-selectin and platelet endothelial cell adhesion molecule-1 were significantly lower in patients with renal cancer than they were in controls, Plasma ICAM-1 was higher in metastatic patients (M+) than they were in nonmetastatic (M-) patients: median = 687 ng/ml, range = 294-1091, n = 12 versus median = 408 ng/ml, range = 217-1375, n = 64 (P = 10(-4)), ICAM-1 and bFGF blood values were correlated with the size of the primary tumor, The interleukin 6 and tumor necrosis factor-alpha (TNF-alpha) values of these patients have been previously published and are included in the survival analysis, Univariate analysis showed that bFGF, ICAM-1, interleukin 6, and TNF-alpha, before treatment, were prognostic factors, In multivariate analysis for proportional hazard regression, only TNF-alpha was an independent prognostic indicator, with a normal plasma TNF-alpha being highly predictive for a good prognosis in patients with untreated renal cell carcinoma.
引用
收藏
页码:2451 / 2458
页数:8
相关论文
共 50 条
  • [21] Prognostic factors in renal cell carcinoma
    Börje Ljungberg
    Der Urologe, 2004, 43 : 119 - 120
  • [22] Prognostic factors for survival of patients with metastatic renal cell carcinoma
    Ohlmann, C. -H.
    UROLOGE, 2009, 48 (06): : 625 - 626
  • [23] Histopathological analysis of angiogenic factors in renal cell carcinoma
    Yagasaki, H
    Kawata, N
    Takimoto, Y
    Nemoto, N
    INTERNATIONAL JOURNAL OF UROLOGY, 2003, 10 (04) : 220 - 227
  • [24] Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma
    Mian, BM
    Bhadkamkar, N
    Slaton, JW
    Pisters, PWT
    Daliani, D
    Swanson, DA
    Pisters, LL
    JOURNAL OF UROLOGY, 2002, 167 (01): : 65 - 70
  • [25] Prognostic Factors in Patients with Renal Cell Carcinoma and Brain Metastases
    Sperduto, P. W.
    Deegan, B. J.
    Li, J.
    Jethwa, K. R.
    Brown, P. D.
    Lockney, N. A.
    Beal, K.
    Rana, N. G.
    Attia, A.
    Shanley, R.
    Lou, E.
    Zahra, A.
    Buatti, J.
    Molitoris, J. K., Jr.
    Yu, J. B.
    Chiang, V. L.
    Masucci, G. L.
    Roberge, D.
    Olson, A. C.
    Kirkpatrick, J. P.
    Braunstein, S. E.
    Sneed, P. K.
    Shi, D. D.
    Shih, H. A.
    Mehta, M. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S169 - S170
  • [26] MULTIVARIATE ANALYSIS OF CYTOKINES AND ANGIOGENIC FACTORS (CAFS) AND ESTABLISHED PROGNOSTIC PARAMETERS IN METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS (PTS) RECEIVING PAZOPANIB OR PLACEBO
    Zurita-Saavedra, A.
    Liu, Y.
    Lin, Y.
    Tran, H. T.
    Pandite, L. N.
    Heymach, J. V.
    ANNALS OF ONCOLOGY, 2012, 23 : 261 - 261
  • [27] Prognostic factors in patients with advanced renal cell carcinoma.
    Pardo, P.
    Muriel, C.
    Esteban, E.
    Izquierdo, M.
    Astudillo, A.
    Martinez-Camblor, P.
    Corral, N.
    Crespo, G.
    Berros, J. P.
    Lacave, A. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [28] Determination of Angiogenic Factors in Serum by Protein Array in Patients with Renal Cell Carcinoma
    Lukesova, S.
    Kopecky, O.
    Vroblova, V.
    Hlavkova, D.
    Andrys, C.
    Moravek, P.
    Cermakova, E.
    FOLIA BIOLOGICA, 2008, 54 (04) : 134 - 140
  • [29] Editorial: Renal cell carcinoma - Prognostic factors
    Marshall, FF
    JOURNAL OF UROLOGY, 2003, 170 (06): : 2233 - 2233
  • [30] Prognostic and Predictive Factors for Renal Cell Carcinoma
    Suarez, Cristina
    Campayo, Marc
    Bastus, Roma
    Castillo, Sergi
    Etxanitz, Olatz
    Guix, Marta
    Sala, Nuria
    Gallardo, Enrique
    TARGETED ONCOLOGY, 2018, 13 (03) : 309 - 331